Dr. Ian MacDonald, Professor Emeritus in the Department of Ophthalmology at the University of Alberta, provides a detailed overview of the current state of genetic therapies for degenerative retinal diseases. Dr. MacDonald further describes Choroideremia, including disease pathology, prognosis, and potential treatment avenues. Finally, Dr. MacDonald explains his reaction to being nominated for a Lifetime Achievement Award by the Canadian College of Medical Geneticists, pointing out some of his own remarkable mentors throughout his career.
http://broadeye.org/ian/